Simplex Trading adds CVS Health Corp (CVS) to its portfolio

CVS Health Corp (CVS) : Simplex Trading added new position in CVS Health Corp during the most recent quarter end. The investment management firm now holds 25,852 shares of CVS Health Corp which is valued at $2,233,613 , the company said in a statement filed on Oct 7, 2016 with the SEC.CVS Health Corp makes up approximately 0.29% of Simplex Trading’s portfolio.

Other Hedge Funds, Including , Exxonmobil Investment Management Inc Tx reduced its stake in CVS by selling 5,768 shares or 2.07% in the most recent quarter. The Hedge Fund company now holds 272,243 shares of CVS which is valued at $23,521,795. CVS Health Corp makes up approx 0.49% of Exxonmobil Investment Management Inc Tx’s portfolio.New England Research Management boosted its stake in CVS in the latest quarter, The investment management firm added 4,200 additional shares and now holds a total of 14,885 shares of CVS Health Corp which is valued at $1,283,087. CVS Health Corp makes up approx 1.08% of New England Research Management’s portfolio.First American Trust Fsb reduced its stake in CVS by selling 3,646 shares or 34.13% in the most recent quarter. The Hedge Fund company now holds 7,037 shares of CVS which is valued at $606,589. CVS Health Corp makes up approx 0.19% of First American Trust Fsb’s portfolio. Norman Fields Gottscho Capital Management sold out all of its stake in CVS during the most recent quarter. The investment firm sold 41,317 shares of CVS which is valued $3,561,525.Washington Trust Bank reduced its stake in CVS by selling 500 shares or 6.6% in the most recent quarter. The Hedge Fund company now holds 7,071 shares of CVS which is valued at $609,520. CVS Health Corp makes up approx 0.15% of Washington Trust Bank’s portfolio.

CVS Health Corp closed down -0.09 points or -0.10% at $86.4 with 43,46,345 shares getting traded on Friday. Post opening the session at $86.56, the shares hit an intraday low of $86.17 and an intraday high of $86.74 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.

On the company’s financial health, CVS Health Corp reported $1.32 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $1.30. The company had revenue of $43725.00 million for the quarter, compared to analysts expectations of $44281.46 million. The company’s revenue was up 17.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Investors should note that on Sep 22, 2016, CVS Health Corp announced a cash dividend of $0.4250. The company’s management has announced Oct 20, 2016 as the ex-dividend date and fixed the record date on Oct 24, 2016. The payable date has been fixed on Nov 3, 2016.

Many Wall Street Analysts have commented on CVS Health Corp. Company shares were Reiterated by Mizuho on Aug 4, 2016 to “Buy”, Firm has raised the Price Target to $ 111 from a previous price target of $108 .Company shares were Reiterated by Deutsche Bank on Aug 3, 2016 to “Hold”, Firm has raised the Price Target to $ 108 from a previous price target of $99 .

CVS Health Corporation together with its subsidiaries is a pharmacy company. The Company operates through three business segments: Pharmacy Services Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services Novologix and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs and an assortment of general merchandise including over-the-counter drugs beauty products and cosmetics personal care products convenience foods photo finishing seasonal merchandise and greeting cards through the Company’s retail stores online retail pharmacy Websites and retail healthcare clinics. The Corporate segment provides management and administrative services to support the overall operations of the Company. The Company through its wholly owned subsidiary Omnicare Inc. provides pharmacy services to long term care facilities.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

CVS Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on CVS Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.